Chat Live with a Dana-Farber Lymphoma Expert

0

Lymphoma: How do we treat it? Where are future therapies headed?

Ann LaCasce, MD

On Wednesday, Dec. 18, Ann LaCasce, MD, of the Dana-Farber/Brigham and Women’s Cancer Center Adult Lymphoma Program will answer your questions about lymphoma care in a live video webchat. The 45-minute chat starts at 1 p.m. EST and will air live on Dana-Farber’s YouTube page.

LaCasce will discuss current treatment options as well as future therapies for lymphoma.

If you have a question for Dr. LaCasce, email webchats@dfci.harvard.edu. You can also submit questions by sending us a Tweet @DanaFarber using the hashtag #DFCIWebchat.

Bookmark the webchat video page and tune in live on Dec. 18 at 1 p.m. EST. You can also add the event to your calendar or RSVP on Facebook.

Comments Sort By Newest

Leave a Reply

Your email address will not be published. Required fields are marked *

Blue Captcha Image
Refresh

*

Most Read Stories

Sorry. No data so far.

Make An Appointment

For adults: 877-960-1562

Quick access: Appointments as soon as the next day for new adult patients

For children: 888-733-4662

All content in these blogs is provided by independent writers and does not represent the opinions or advice of Dana-Farber Cancer Institute or its partners.

Latest Tweets

Dana-Farber @danafarber
#CheerforDanaFarber and support Dana-Farber’s mission to conquer cancer. Learn more: https://t.co/bsCf9Ywdnthttps://t.co/oZ2SjWSICZ
Dana-Farber @danafarber
CAR T-cell therapy is a kind of #cellulartherapy which uses a patient’s own immune system cells to attack cancer.… https://t.co/BIHvWOQbl0
Dana-Farber @danafarber
RT @DrChoueiri: Shaun Tierney and family: living proof of @DanaFarber outstanding care @TheJimmyFund #BeatCancer https://t.co/SNEwgFmYhy

Republish our posts on your blog

Interested in sharing one of our stories on your blog? Feel free to republish this content! We just ask that you credit Dana-Farber, link to the original article, and refrain from making edits that change the original context. Questions? Email the editors at insight_blog@dfci.harvard.edu.